Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors.
about
Clonal origin and spread of metastatic prostate cancerConsiderations for patient selection for focal therapyFocal therapy in prostate cancer: the current situationFocal laser ablation of prostate cancer: numerical simulation of temperature and damage distributionFocal therapy for prostate cancer: rationale and treatment opportunities.Focal therapy in the management of localized prostate cancer.Heterogeneity of miRNA expression in localized prostate cancer with clinicopathological correlationsA mouse model of heterogeneous, c-MYC-initiated prostate cancer with loss of Pten and p53.Focal laser interstitial thermotherapy (LITT) at 980 nm for prostate cancer: treatment feasibility in Dunning R3327-AT2 rat prostate tumour.Image-guided prostate cryosurgery: state of the art.Staging of prostate cancer.Focal ablation of prostate cancer: four roles for magnetic resonance imaging guidance.Determining prostate cancer-specific death through quantification of stromogenic carcinoma area in prostatectomy specimens.Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study.Heterogeneity in intratumor distribution of p53 mutations in human prostate cancerFocal therapy for prostate cancer: The current status.The male lumpectomy: rationale for a cancer targeted approach for prostate cryoablation. A review.Residual tumor potentially left behind after local ablation therapy in prostate adenocarcinoma.Markers of field cancerization: proposed clinical applications in prostate biopsiesAn update on focal therapy for prostate cancer.Innovative strategies for image-guided proton treatment of prostate cancer.Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience.Imaging and Markers as Novel Diagnostic Tools in Detecting Insignificant Prostate Cancer: A Critical OverviewCorrelation of MR imaging and MR spectroscopic imaging findings with Ki-67, phospho-Akt, and androgen receptor expression in prostate cancer.High-intensity focused ultrasound: where are we and where to from here?Targeted focal therapy for prostate cancer: a review of the literature.The complexity of prostate cancer: genomic alterations and heterogeneity.Pros and cons of focal therapy for localised prostate cancer.Clinical variability and molecular heterogeneity in prostate cancer.The delineation of intraprostatic boost regions for radiotherapy using multimodality imaging.Incidence of intraductal carcinoma, multifocality and bilateral significant disease in radical prostatectomy specimens from Japan and United States.Anatomically versus biologically unifocal prostate cancer: a pathological evaluation in the context of focal therapy.Quantitative tissue analyses of prostate cancer foci in an unselected cystoprostatectomy series.Pathologic staging of prostate carcinoma. What are the issues?Focal application of low-dose-rate brachytherapy for prostate cancer: a pilot study.Focal therapy for prostate cancer: the technical challenges.High-resolution genome-wide copy-number analysis suggests a monoclonal origin of multifocal prostate cancer.Contrast-enhanced ultrasound as support for prostate brachytherapy treatment planning.Pathologic characteristics of prostatic adenocarcinomas: a mapping analysis of Korean patients.PTEN losses exhibit heterogeneity in multifocal prostatic adenocarcinoma and are associated with higher Gleason grade.
P2860
Q26752873-AC32C086-E867-4548-A6D4-243C890DE3BFQ26865125-6607DCBC-618E-4600-B4C7-5C720CF9143EQ28242346-23ABF1DE-3BB9-441C-875A-BBC275CA0360Q30501278-47BC8F85-844E-42F0-8258-E1A8304E0F46Q33702259-F1A5DEAE-F7D5-4897-8E79-6B5BD9C76688Q33790382-E42EFA96-D588-4582-8375-6CA11AA55775Q33811802-DD17A8ED-2B85-44C6-ABC6-C1F68DB725C9Q33936343-2FEFDA87-1439-4451-BA50-7D8CA14DA1C9Q34012228-F2035FC6-B363-45A7-993A-F7B1ACD20E3EQ34504216-6606F80C-A563-4C8B-B270-0FA20CCD9341Q34634756-C9F8622D-BA06-4FAD-B7D2-47E47A4C48EDQ34669610-A3F1A08F-6154-4475-BD41-B6C12DC81F12Q34756267-BD2627A0-2D49-4453-9C63-2A2ED7F44D26Q35262855-7D4DCCD5-138E-4739-A4E6-1993E82AAA2FQ35796293-4D45AF54-D1FD-46DB-A87D-EB949840A04FQ35827748-A558D9B0-20F9-48DF-BD9B-ACAFF4055DBBQ35843518-8B92FD50-A3B2-4DC0-9BB3-E72B0706388AQ35963464-341BF7FA-620B-4F52-A0BF-E77398614D05Q35991148-991BFFDD-9CDA-4004-A5B8-F25BBC0079F5Q36145325-22017395-08CD-4F26-890F-5E89D3741BE3Q36427226-C320D3B5-332A-4377-8674-A6BCDC851D59Q36638498-68A93CC3-505C-47E9-A2FD-B9F9B75A5E43Q36979944-B35DA088-EC77-4A04-BAEA-CB02B6A3824FQ37401554-8A2AA073-F6D7-476A-A2D1-6CECF82406CEQ37656210-81C47033-239A-47BB-BC58-7CB29DCB1EF7Q37905558-05ED8724-5DCB-4987-899A-095FF24B12E5Q38058243-AD9131E7-3E87-4192-9F82-AC04A5BFDDAFQ38807805-4EED25E0-EF89-43B5-AB97-5B25D94C2D9EQ38808811-24B98F3C-B995-4B20-9FF8-2B0FE1157D7FQ38851017-34A888ED-0E21-4F4E-BA26-30A75C572ABBQ39245025-9B5705B0-8794-4708-9269-4BF1D3A7F137Q39576290-0E518691-7920-45FD-8DEC-0115584D32F9Q39672788-0BCBE3A3-F04B-4BD1-AA3A-2F41589D2882Q40933439-C1B7319B-BFD8-4CD5-BED3-F0B9EF8BC3EEQ41011798-F6EDEB9D-CDC3-43FB-B661-BEC9C43B3EBDQ41689116-9B4EFDAF-7C89-494A-B426-AAC773F3521DQ42636324-FDA1B752-EFDE-4E20-8155-33849613CAEEQ42935166-085CEBAD-1CEF-43A3-8130-0E2D73460D62Q44240274-589A41AF-3D91-4C63-A4DE-51E3C5BDB128Q45359397-5C2EA0C7-1DB9-4F5B-9ABB-58FF63449039
P2860
Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Multiple cancers in the prosta ...... ized versus incidental tumors.
@en
Multiple cancers in the prosta ...... ized versus incidental tumors.
@nl
type
label
Multiple cancers in the prosta ...... ized versus incidental tumors.
@en
Multiple cancers in the prosta ...... ized versus incidental tumors.
@nl
prefLabel
Multiple cancers in the prosta ...... ized versus incidental tumors.
@en
Multiple cancers in the prosta ...... ized versus incidental tumors.
@nl
P2093
P1433
P1476
Multiple cancers in the prosta ...... ized versus incidental tumors.
@en
P2093
P304
P356
10.1002/1097-0142(19921101)70:9<2313::AID-CNCR2820700917>3.0.CO;2-T
P407
P577
1992-11-01T00:00:00Z